Afra Hadjizadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Afra Hadjizadeh has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Davod Mohebbi-Kalhori
Chemical Engineering Department, University of Sistan and Baluchestan, Zahedan, Iran
3 shared publications - Saeid Moghassemi
Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
3 shared publications - Bahareh Kheilnezhad
Department of Chemical Engineering and Materials Research Institute, The Pennsylvania State University 2 , University Park, Pennsylvania 16802
2 shared publications Farzaneh Ghasemkhah
Nanotechnology Institute, Amirkabir University of Technology, Tehran, Iran
2 shared publicationsFatemeh Kashani-Asadi-Jafari
Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran
2 shared publicationsKobra Omidfar
Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- 15 February 2023
- Published by Springer Nature in Fibers and Polymers
- Vol. 24 (2) , 515-523
Magnetic-Field-Assisted Emulsion Electrospinning System: Designing, Assembly, and Testing for the Production of PCL/Gelatin Core–Shell Nanofibers
- 15 February 2023
- Published by Springer Nature in Fibers and Polymers
- Vol. 24 (2) , 515-523
Magnetic-Field-Assisted Emulsion Electrospinning System: Designing, Assembly, and Testing for the Production of PCL/Gelatin Core–Shell Nanofibers
- 18 August 2022
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 39 (6) , 552-562
Improvement of ascorbic acid delivery into human skin via hyaluronic acid-coated niosomes
Hyaluronic acid (HA) as a covering agent was incorporated into the ascorbic acid (AA)-niosomes to improve the performance of AA delivery systems into the skin. The preparation method: Thin film hydration. Characterisation tests: Field emission scanning electron microscopy, fourier transform infra-red spectroscopy, dynamic light scattering, UV-Visible, zeta potential, Franz diffusion cell, and flowcytometry. The niosomes with 10% w/w HA possessed the largest mean particle diameter of 341.0 ± 48.09 nm with PDI value of 0.29 ± 0.05, and the lowest zeta potential of −38.70 ± 0.27 mv. The drug encapsulation efficiency of this sample was 56.55 ± 0.99%, and in-vitro drug release test showed AA released in two slow and fast phases. Moreover, the highest amount of drug penetration and accumulation was related to this sample, recorded 116.55 ± 7.54 and 134.8 ± 10.04 µg/cm2, respectively. Niosomes coated with 10% w/w HA showed the greatest potential for improving the antioxidant activity of AA penetration into the skin.
- 18 August 2022
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 39 (6) , 552-562
Improvement of ascorbic acid delivery into human skin via hyaluronic acid-coated niosomes
Hyaluronic acid (HA) as a covering agent was incorporated into the ascorbic acid (AA)-niosomes to improve the performance of AA delivery systems into the skin. The preparation method: Thin film hydration. Characterisation tests: Field emission scanning electron microscopy, fourier transform infra-red spectroscopy, dynamic light scattering, UV-Visible, zeta potential, Franz diffusion cell, and flowcytometry. The niosomes with 10% w/w HA possessed the largest mean particle diameter of 341.0 ± 48.09 nm with PDI value of 0.29 ± 0.05, and the lowest zeta potential of −38.70 ± 0.27 mv. The drug encapsulation efficiency of this sample was 56.55 ± 0.99%, and in-vitro drug release test showed AA released in two slow and fast phases. Moreover, the highest amount of drug penetration and accumulation was related to this sample, recorded 116.55 ± 7.54 and 134.8 ± 10.04 µg/cm2, respectively. Niosomes coated with 10% w/w HA showed the greatest potential for improving the antioxidant activity of AA penetration into the skin.
- 7 July 2022
- Published by Walter de Gruyter GmbH in Journal of Polymer Engineering
- Vol. 42 (8) , 776-786
Chitosan nanoparticles encapsulated into PLA/gelatin fibers for bFGF delivery
Electrospinning is a trendy method because of the ease of use and the high surface-to-volume ratio. The mechanical and biological properties of polylactic acid (PLA) make it one of the most enticing polymers. Gelatin and PLA together are thought to enhance cellular behavior and hydrophilicity of scaffolds. Furthermore, chitosan nanoparticles (CNPs) can be incorporated into PLA fibers to achieve controlled growth factor release. This study utilized PLA–gelatin nanofibrous scaffolds in which CNPs were encapsulated within PLA fibers to achieve a controlled release of basic fibroblast growth factor (bFGF). To produce CNPs, a simple ionic gelation reaction was used. The optimal diameter of CNPs was determined by investigating chitosan to tricalciumphosphatesodium (TPP) ratio and TPP concentration. Using a spectrophotometer, we measured the release rate of bFGF from CNPS and scaffolds. Images from a scanning electron microscope (SEM) were used to assess the effect of various concentrations of PLA and gelatin on fiber diameter. The results showed that PLA–gelatin scaffolds could stimulate the release of growth factors and promote cell proliferation. Using a two-jet electrospinning device to produce PLA–gelatin fibers in combination with CNPs incorporated within PLA fibers to release the bFGF growth factor is the novelty of this study.
- 7 July 2022
- Published by Walter de Gruyter GmbH in Journal of Polymer Engineering
- Vol. 42 (8) , 776-786
Chitosan nanoparticles encapsulated into PLA/gelatin fibers for bFGF delivery
Electrospinning is a trendy method because of the ease of use and the high surface-to-volume ratio. The mechanical and biological properties of polylactic acid (PLA) make it one of the most enticing polymers. Gelatin and PLA together are thought to enhance cellular behavior and hydrophilicity of scaffolds. Furthermore, chitosan nanoparticles (CNPs) can be incorporated into PLA fibers to achieve controlled growth factor release. This study utilized PLA–gelatin nanofibrous scaffolds in which CNPs were encapsulated within PLA fibers to achieve a controlled release of basic fibroblast growth factor (bFGF). To produce CNPs, a simple ionic gelation reaction was used. The optimal diameter of CNPs was determined by investigating chitosan to tricalciumphosphatesodium (TPP) ratio and TPP concentration. Using a spectrophotometer, we measured the release rate of bFGF from CNPS and scaffolds. Images from a scanning electron microscope (SEM) were used to assess the effect of various concentrations of PLA and gelatin on fiber diameter. The results showed that PLA–gelatin scaffolds could stimulate the release of growth factors and promote cell proliferation. Using a two-jet electrospinning device to produce PLA–gelatin fibers in combination with CNPs incorporated within PLA fibers to release the bFGF growth factor is the novelty of this study.
- 7 April 2022
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (4) , 1766-1778
Ibuprofen-Loaded Electrospun PCL/PEG Nanofibrous Membranes for Preventing Postoperative Abdominal Adhesion
Electrospun nanofibrous membranes are a widely used physical barrier for reducing postoperative adhesion. However, these physical barriers could not prevent adhesion formation completely. Because a high-intensity inflammation occurs in the surgical area, the presence of relevant drugs to control such an inflammation is desperately needed. In this study, we fabricated an electrospun composite ibuprofen-loaded poly(ethylene glycol) (PEG)/polycaprolactone (PCL) nanofibrous membrane (NFM) to prevent abdominal adhesions. This membrane aimed to act as a barrier between the abdominal wall and surrounding tissues, without interrupting mass transfer and normal wound healing. Among various fabricated composite NFMs, PCL/25PEG-6% NFMs showed the lowest fiber diameter (448.8 ± 124.4 nm), the smallest pore size (in vitro toxicity examination of PCL/25PEG-6% toward fibroblast cells demonstrated a cell viability of ≈82% after 3 days, proving its prolonged antiadhesion ability. In addition, the low number of adherent cells with a rounded shape and low cell proliferation on these NFMs indicated their special antiadhesive effects. Collectively, these results indicated that the PCL/25PEG-6% membrane might be a suitable barrier to prevent abdominal adhesion.
- 7 April 2022
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (4) , 1766-1778
Ibuprofen-Loaded Electrospun PCL/PEG Nanofibrous Membranes for Preventing Postoperative Abdominal Adhesion
Electrospun nanofibrous membranes are a widely used physical barrier for reducing postoperative adhesion. However, these physical barriers could not prevent adhesion formation completely. Because a high-intensity inflammation occurs in the surgical area, the presence of relevant drugs to control such an inflammation is desperately needed. In this study, we fabricated an electrospun composite ibuprofen-loaded poly(ethylene glycol) (PEG)/polycaprolactone (PCL) nanofibrous membrane (NFM) to prevent abdominal adhesions. This membrane aimed to act as a barrier between the abdominal wall and surrounding tissues, without interrupting mass transfer and normal wound healing. Among various fabricated composite NFMs, PCL/25PEG-6% NFMs showed the lowest fiber diameter (448.8 ± 124.4 nm), the smallest pore size (in vitro toxicity examination of PCL/25PEG-6% toward fibroblast cells demonstrated a cell viability of ≈82% after 3 days, proving its prolonged antiadhesion ability. In addition, the low number of adherent cells with a rounded shape and low cell proliferation on these NFMs indicated their special antiadhesive effects. Collectively, these results indicated that the PCL/25PEG-6% membrane might be a suitable barrier to prevent abdominal adhesion.
- 2 March 2022
- Published by Springer Nature in Polymer Bulletin
- Vol. 80 (2) , 1155-1177
Advances in self-healing hydrogels to repair tissue defects
- 2 March 2022
- Published by Springer Nature in Polymer Bulletin
- Vol. 80 (2) , 1155-1177
Advances in self-healing hydrogels to repair tissue defects
- 7 January 2022
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (2) , 394-412
Near-Field Electrospinning: Crucial Parameters, Challenges, and Applications
Near-field electrospinning (NFES) is a micro- or nanofiber production technology based on jetting molten polymer or polymer solution. Thanks to the programmable collector and nozzle movement, it can generate designed patterns in the presence of an electric field. Despite a few shortcomings of NFES, its high resolution, simplicity, precision, high throughput, reproducibility, and low costs have convinced researchers to employ it for various purposes. Furthermore, as the paradigm of fiber-based structures shifts from random textures toward delicate designs, NFES can bridge the gap between existing inefficient processes and aspired technologies for precise patterning. NFES facilitates the production of ultrafine nanofibers because it can be used to fabricate them in every laboratory. These robust fibers are convenient tools for small and additive manufacturing. As such, NFES is considered a potent additive fabrication technology that facilitates the production of complicated patterns as well. It is suggested that near-field electrospun fibers exhibit outstanding results in various applications, owing to their precise and controllable positioning. Meanwhile, the ongoing development of NFES has yet to reach its climax, making it attractive for further research. In this review, the basic principles of NFES, derivatives, limitations, and applications in nanomanufacturing, tissue engineering, microscale electronics, biosensors, and optics are presented.
- 7 January 2022
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (2) , 394-412
Near-Field Electrospinning: Crucial Parameters, Challenges, and Applications
Near-field electrospinning (NFES) is a micro- or nanofiber production technology based on jetting molten polymer or polymer solution. Thanks to the programmable collector and nozzle movement, it can generate designed patterns in the presence of an electric field. Despite a few shortcomings of NFES, its high resolution, simplicity, precision, high throughput, reproducibility, and low costs have convinced researchers to employ it for various purposes. Furthermore, as the paradigm of fiber-based structures shifts from random textures toward delicate designs, NFES can bridge the gap between existing inefficient processes and aspired technologies for precise patterning. NFES facilitates the production of ultrafine nanofibers because it can be used to fabricate them in every laboratory. These robust fibers are convenient tools for small and additive manufacturing. As such, NFES is considered a potent additive fabrication technology that facilitates the production of complicated patterns as well. It is suggested that near-field electrospun fibers exhibit outstanding results in various applications, owing to their precise and controllable positioning. Meanwhile, the ongoing development of NFES has yet to reach its climax, making it attractive for further research. In this review, the basic principles of NFES, derivatives, limitations, and applications in nanomanufacturing, tissue engineering, microscale electronics, biosensors, and optics are presented.
- 25 October 2021
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 72 (2) , 144-161
Fabrication and characterization of polymeric nano/micro fibers containing silver nanoparticles for biomedical applications
Polyethylene terephthalate (PET) pre-prepared nano/micro fibers were treated by sodium hydroxide (NaOH) aqueous solution and then AgNPs were loaded on them through the soaking process. In total, eight samples were created. Then they were characterized by field emission scanning electron microscopy (FESEM), scanning electron microscopy (SEM), X-ray energy diffraction (EDS) spectroscopy and Fourier transform infrared (FTIR). Disk diffusion and colony counting tests were also performed. Samples containing AgNPs had growth inhibition zones with diameters between 19 and 26 mm while control samples had no inhibition zone. PET microfibers containing AgNPs had a larger inhibition zone on Staphylococcus aureus compared to other samples. The innovation of this research is the placement of AgNPs on the hydrophilic PET micro/nano fibers. Graphical Abstract
- 25 October 2021
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 72 (2) , 144-161
Fabrication and characterization of polymeric nano/micro fibers containing silver nanoparticles for biomedical applications
Polyethylene terephthalate (PET) pre-prepared nano/micro fibers were treated by sodium hydroxide (NaOH) aqueous solution and then AgNPs were loaded on them through the soaking process. In total, eight samples were created. Then they were characterized by field emission scanning electron microscopy (FESEM), scanning electron microscopy (SEM), X-ray energy diffraction (EDS) spectroscopy and Fourier transform infrared (FTIR). Disk diffusion and colony counting tests were also performed. Samples containing AgNPs had growth inhibition zones with diameters between 19 and 26 mm while control samples had no inhibition zone. PET microfibers containing AgNPs had a larger inhibition zone on Staphylococcus aureus compared to other samples. The innovation of this research is the placement of AgNPs on the hydrophilic PET micro/nano fibers. Graphical Abstract
- Open Access
Niosome encapsulated doxycycline-hyclate for potentiation of acne therapy: formulation and characterization
Acne is the pilosebaceous units’ disorder. The most important cause of acne is the colonization of bacteria in the follicles. Among antibiotics, doxycycline-hyclate kills a wide range of bacteria. To prevent oral administration’s side effects, overcome the barriers of conventional topical treatment, and improve the therapeutic effectiveness, doxycycline-hyclate was loaded into four niosomal formulations with different percentages of constituents (span 60 and cholesterol) prepared by the thin-film hydration method. Then, one of the four formulations with the most appropriate particle size of 362.88 ± 13.05 nm to target the follicles, percentage of drug entrapment efficiency of 56.3 ± 2.1%, in vitro drug release of 54.93 ± 1.99% after 32 hours, and the lowest permeation of the drug through the Wistar rat skin, was selected. Then, its toxicity on human dermal fibroblasts (HDF) by MTT method after 72 hours, its antibacterial activity against the main acne-causing bacteria via antibiogram test, and its effect on Wistar rat skin drug deposition were measured. Improved cell viability, increased antibacterial activity, and an approximately three-fold increase in drug deposition were the optimal niosomal formulation features relative to the free drug. Overall, this study demonstrated the ability of nano-niosomes containing doxycycline-hyclate to treat skin acne.
Open AccessNiosome encapsulated doxycycline-hyclate for potentiation of acne therapy: formulation and characterization
Acne is the pilosebaceous units’ disorder. The most important cause of acne is the colonization of bacteria in the follicles. Among antibiotics, doxycycline-hyclate kills a wide range of bacteria. To prevent oral administration’s side effects, overcome the barriers of conventional topical treatment, and improve the therapeutic effectiveness, doxycycline-hyclate was loaded into four niosomal formulations with different percentages of constituents (span 60 and cholesterol) prepared by the thin-film hydration method. Then, one of the four formulations with the most appropriate particle size of 362.88 ± 13.05 nm to target the follicles, percentage of drug entrapment efficiency of 56.3 ± 2.1%, in vitro drug release of 54.93 ± 1.99% after 32 hours, and the lowest permeation of the drug through the Wistar rat skin, was selected. Then, its toxicity on human dermal fibroblasts (HDF) by MTT method after 72 hours, its antibacterial activity against the main acne-causing bacteria via antibiogram test, and its effect on Wistar rat skin drug deposition were measured. Improved cell viability, increased antibacterial activity, and an approximately three-fold increase in drug deposition were the optimal niosomal formulation features relative to the free drug. Overall, this study demonstrated the ability of nano-niosomes containing doxycycline-hyclate to treat skin acne.
- 2 August 2021
- Published by Springer Nature in Metals and Materials International
- Vol. 28 (6) , 1525-1535
Effect of ECAP on Physicochemical and Biological Properties of TiO2 Nanotubes Anodized on Commercially Pure Titanium
- 2 August 2021
- Published by Springer Nature in Metals and Materials International
- Vol. 28 (6) , 1525-1535
Effect of ECAP on Physicochemical and Biological Properties of TiO2 Nanotubes Anodized on Commercially Pure Titanium
- Top Cited Papers
- 18 February 2021
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 9 (8) , 2850-2873
A review: progress in preventing tissue adhesions from a biomaterial perspective
Post-operation adhesions are accrued by inflammation and result in tissue adhesions. Fortunately, biomaterials have shown promising anti-adhesive bioactivity for dealing with such issues.
- 18 February 2021
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 9 (8) , 2850-2873
Top Cited PapersA review: progress in preventing tissue adhesions from a biomaterial perspective
Post-operation adhesions are accrued by inflammation and result in tissue adhesions. Fortunately, biomaterials have shown promising anti-adhesive bioactivity for dealing with such issues.